Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2021 Aug 26;22(17):9221. doi: 10.3390/ijms22179221.
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
Xu C, Smith ER, Tiong MK, Ruderman I, Toussaint ND.
J Am Soc Nephrol. 2022 May;33(5):1011-1032. doi: 10.1681/ASN.2021101327. Epub 2022 Mar 1.
Intestinal ischemia.
Debus ES, Müller-Hülsbeck S, Kölbel T, Larena-Avellaneda A.
Int J Colorectal Dis. 2011 Sep;26(9):1087-97. doi: 10.1007/s00384-011-1196-6. Epub 2011 May 4.
Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.
Felsenfeld AJ, Levine BS, Rodriguez M.
Semin Dial. 2015 Nov-Dec;28(6):564-77. doi: 10.1111/sdi.12411. Epub 2015 Aug 25.
SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
Dong QQ, Tu YC, Gao P, Liao QQ, Zhou P, Zhang H, Shu HP, Sun LL, Feng L, Yao LJ.
Theranostics. 2024 Jan 1;14(2):861-878. doi: 10.7150/thno.87317. eCollection 2024.
Sulodexide in venous disease.
Carroll BJ, Piazza G, Goldhaber SZ.
J Thromb Haemost. 2019 Jan;17(1):31-38. doi: 10.1111/jth.14324. Epub 2018 Dec 7.
Hyperphosphataemia: treatment options.
Malberti F.
Drugs. 2013 May;73(7):673-88. doi: 10.1007/s40265-013-0054-y.
Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-kappaB signaling pathway.
Hao QY, Yan J, Wei JT, Zeng YH, Feng LY, Que DD, Li SC, Guo JB, Fan Y, Ding YF, Zhang XL, Yang PZ, Gao JW, Li ZH.
Gut Microbes. 2024 Jan-Dec;16(1):2351532. doi: 10.1080/19490976.2024.2351532. Epub 2024 May 10.
A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H.
Cells. 2024 Mar 4;13(5):450. doi: 10.3390/cells13050450.
The Role of Gut Dysbiosis in the Bone-Vascular Axis in Chronic Kidney Disease.
Evenepoel P, Dejongh S, Verbeke K, Meijers B.
Toxins (Basel). 2020 Apr 29;12(5):285. doi: 10.3390/toxins12050285.
